The Effects of Treatment With Vemurafenib on the Immune System in Advanced Melanoma
Clinical trial NCT01942993 · TERMINATED
Trial details
- NCT number
- NCT01942993
- Sponsor
- Philip Friedlander
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-11-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.